Therapeutic Drugs: Nitazoxanide
( Listed as "Cryptaz" in the TGA's Orphan Drug List ; US-FDA Registered as "Alinia" for Paediatric Use)

TRI-MED, supplies Nitazoxanide (NTZ) {Trade Name: Alinia ®} a novel broad spectrum anti-infective developed in the USA.

NTZ has been evaluated on a worldwide basis for treating a broad spectrum of gastrointestinal Helminth and protozoal (parasitic) infections, trichomoniasis, bacterial vaginosis and Helicobacter pylori {NTZ is active against Helicobacter pylori in vitro. A double-blind clinical trial intended to evaluate the efficacy of NTZ against Blastocystis hominis is ongoing in Perth, WA under the direction of Prof. Barry Marshall).

The product is available in two pharmaceutical formulations for oral use:

• A 500 mg film-coated tablet (the adult formulation) and
• A powder for re-constitution as a 100 mg / 5ml paediatric suspension.

Both of the above are manufactured in accordance with Good Manufacturing Practices in Belgium. The tablets and powder use standard pharmaceutical excipients.

Prescribing Nitazoxanide to your patient

Nitazoxanide General Information

NTZ Clinical Data sheet for Adult Formula NTZ

NTZ General Information on Paediatric Formula.

NTZ Clinical Data Sheet for Paediatric NTZ Formula (Alinia)

Click here to download the Orphan drug order and payment form.

Click here for the TGA Special Access Scheme (SAS) Proforma
(One Proforma must be completed for each therapeutic
agent you wish to prescribe to your patient)

ALSO IN THIS SECTION
Therapeutic Drugs
De-Nol
Furazolidone
Nitazoxanide
Dicyclomine hydrochloride
Tetracycline
How to Order